Want to track HNSA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hansa Biopharma AB (publ) (HNSA) Statistics
Valuation metrics
Market Cap 2.08B
Enterprise value 3.08B
Trailing P/E (ttm) -4.76
Forward P/E -
PEG ratio -0.83
Price/Sales (ttm) 13.74
Price/Book (mrq) -11.91
Enterprise Value/Revenue 16.18
Enterprise Value/EBITDA -5.66
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 417.57K
Average volume (90 days) 425.47K
Price summary
52-Week low 22.82
52-Week high 42.98
Beta -
50-Day moving average 31.46
200-Day moving average 32.15
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 816:775
Last split Date 16 Mar 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.61%
Operating margin -2.99%
Operational effectiveness
Return on assets -0.59%
Return on equity 2.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.87
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -6.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.65
Total debt (mrq) -
Total Debt/Equity (mrq) -4.15
Current ratio (mrq) 3.63%
Book value per share (mrq) -2.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
